SPARC (Secreted Protein that is Acidic and Rich in Cysteine), a Ca -bin&ng glycoprotein also known as osteonectin, is produced in significant amounts by injured or proliferating cells in vitro.
To elucidate the possible function of SPARC in growth and remodeling, we examined its distribution in embryonic and adult murine tissues.
Immunohistochemistry on adult mouse tissues revealed a preferential association of SPARC protein with epitheia exhibiting high rates of turnover (gut, skin, and glandular tissue).
Fetal tissues
Introduction SPARC is a secreted Ca -binding protein which is induced in conjunction with cell differentiation, proliferation, stress, and certain developmental signals (Holland et al., 1987; Mason et al., 1986a,b; Sage et al. , 1986) . Molecular cloning and protein sequence analysis have shown that SPARC is identical to osteonectin (ON), originally described as a major noncollagenous protein ofbone which bound Ca , hydnoxyapatite, and type I collagen (Bolanden et al., 1988; Mason et al., 1986b; Young et al., 1986; Rombeng et al., 1985; Tenmine et al., 1981) . SPARC is also identical to BM-40, a product of a basement membrane-secreting tumor cell line (Mann et al., 1987;  Dziadek et al., 1986), and to an Mr 43 KD glycopnotein, synthesized in vitro by cells ofthe vessel wall as well as by other normal and transformed cells derived from all primordial germ layers (Sage et al., 1981 (Sage et al., , 1984 . ON was also found in dentin, periodontal ligament (Tung et al., 1985) , and platelets (Stennen et al., 1986) , and was a synthetic product ofgingival and ligament fibnoblasts (Zung et al., 1986; Wasi et al., 1984) and calvarial cells in vitro (Otsuka et al., 1984) . The Mr 43 KD protein was identified as a "culture cell migration, proliferation, serum deprivation, and endotoxinmediated injury (Sage, 1986a; Sage et al., 1986) .
Since bone ON/SPARC is now known to be a potent inhibitor of hydroxyapatite formation (Rombeng et al., 1985) , it has been suggested that the protein might inhibit (Engel et al., 1987) Although SPARC mRNA levels are decreased in virally transformed cells (Mason et al., 1986a; Young et al., 1986) , it (Sage et al., 1984 (Sage et al., , 1986 
Immunohistological Studies
Immunofluorescence microscopy was performed on cells grown on glass coyerslips in vitro as previously described (Sage et al., 1984 (Sage et al., , 1986 Figure  2D, lane 3) , SPARC protein was noticeably absent from the spaces between or under the cells. Figure 2C shows Figure 4A ); this tissue, however, was negative in the adult (Table 1) . Thoracic (and caudal, not shown) somites from 14-day embryos expressed SPARC antigen ( Figure 4B ). In developing bone, SPARC was localized primarily to the perichon. drium/peniosteum in 18-day embryos ( Figure  5A ), but a more genenalized distribution was seen in newborn (4-5-day) long bone, where SPARC was associated with nonhypertnophic chondrocytes ( Figure   SB ). In the newborn, staining for SPARC was also seen in peniosteum and penichondnium, and in association with osteoblasts and newly synthesized osteoid ( Figure  SC) . Chondnogenic tissues from 12-day embryos were also positive for SPARC (Table 1 , footnote); however, tongue and intestine from these animals were negative. Some ofthe other tissues listed as positive for SPARC in I#{224}ble 1 are shown in Figure 6 . SPARC was cleanly associated with prolifenating epithelia in several tissues. In Figure 6A , the epidermal covering of newborn skull stained intensely with anti-SPARC IgG; for comparison, anti-FN IgG identified antigen in the connective tissue intenstitium ofthe skin ( Figure 6B ). In newborn thymus, SPARC was associated with the epithelial processes that provide support
for T-cell populations ( Figure  6C ). At this stage of development, both epidermal and thymic epithelial cells are undergoing generalized proliferation.
In lactating mammary gland, SPARC was associated with both the ductal and alveolar epithelia that proliferate in response to hormonal stimuli during late stages of the neproductive cycle ( Figure  6D ). Figure 7A , SPARC produced a spectrum similar to that shown for intact BM-40 (Engel et al., 1987) , with a promi. nent shoulder at 220 nm. In the presence of 2.5 mM CaCl2 at pH et al., 1988; Holland et al., 1987) .
The earliest appearance ofSPARC mRNA was reported in the 8.5 day mouse embryo (Reichert's membrane, trophoblastic giant cells) (Holland et al., 1987) . It was seen in embryonic chondnogenic tissues at day 12 (Table  1) , and was rather widely distributed after 13.5 days (Nomuna et al., 1988; Mason et al., 1986a) (l#{224}ble1) .
We note an interesting coincidence between the distribution of SPARC and fos mRNA in embryonic mouse bone (Dony and Gruss, 1987) .
Our data show SPARC protein in the penichondnium/peniosteum and in the mesodermal web of the 18-day paw, a tissue that exhibits a rapid proliferative phase at this stage of embryogenesis( Figure  SA) . A,B) , newborn thymus (C), and adult lactating mammary gland (D)were exposed to anti-SPARC lgG (A,C,D) orto rabbit anti-human FN (B), and were visualized by RITC indirect immunofluorescence.
In contrast to FN, which was distributed primarily in the denmal interstitium (B), SPARC exhibited a preferential localization in the epidermis (A). SPARC was also apparent in the epithelial reticular cells of newborn thymic stroma (C) nd in both ductal and alveolar epithelia of lactating mammary gland (0 
